✦ LIBER ✦

Four-Year Treatment Results of Neovascular Age-Related Macular Degeneration With Ranibizumab and Causes for Discontinuation of Treatment

✍ Scribed by Mads Krüger Falk; Henrik Kemp; Torben Lykke Sørensen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ranibizumab treatment in patients with n

✍ Torben Lykke Sørensen; Henrik Kemp 📂 Article 📅 2010 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 105 KB

Measuring the benefit of 4 years of intr

✍ Pushpoth, S.; Sykakis, E.; Merchant, K.; Browning, A. C.; Gupta, R.; Talks, S. J 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 161 KB

Predictors of 1-year visual outcome in n

✍ Sara B. Bloch; Morten la Cour; Birgit Sander; Louise K. H. Hansen; Josefine Fuch 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 222 KB

Retinal venular calibre dilatation after

✍ Sanjeewa S Wickremasinghe; Robyn H Guymer; Tien Y Wong; Ryo Kawasaki; Wanling Wo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

One-year results of intravitreal ranibiz

✍ Seungbum Kang; Young-Jung Roh 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB

Results of One-Year's Treatment with Ran

✍ Salomon Y. Cohen; Lise Dubois; Ramin Tadayoni; Franck Fajnkuchen; Sylvia Nghiem- 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 552 KB